Research: Evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund and the Life Sciences Innovative Manufacturing Fund

Office for Artificial Intelligence UK Published: 2026-04-13 23:01:02

Findings from the early‑stage evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund and its successor, the Life Sciences Innovative Manufacturing Fund.

No full content stored. Use “Open Source” to read the original.

Open Source → View topic (Trending) →

Recommended reads

Notice: UK-Germany joint statement on advanced AI safety and security From UK

A joint statement by the UK and Germany on collaborating to ensure advanced AI is developed safely and its risks are rigorously understood and managed.

Office for Artificial Intelligence · UK 2026-06-30

Guidance: Person Data Standard: overview and guidance From UK

Learn about the Alpha Person Data Standard and how to provide feedback.

Office for Artificial Intelligence · UK 2026-06-30

Guidance: Person Standard Use Case: HMPPS Core Person Service From UK

Learn how the Person Data Standard can be applied in practice when a single authoritative identity is required for person data.

Office for Artificial Intelligence · UK 2026-06-30